An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
Clinical trial NCT00744757 · COMPLETED
Trial details
- NCT number
- NCT00744757
- Sponsor
- Johnson & Johnson Taiwan Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-09-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.